2017
DOI: 10.1186/s12870-017-1011-9
|View full text |Cite
|
Sign up to set email alerts
|

Production of BP178, a derivative of the synthetic antibacterial peptide BP100, in the rice seed endosperm

Abstract: BackgroundBP178 peptide is a synthetic BP100-magainin derivative possessing strong inhibitory activity against plant pathogenic bacteria, offering a great potential for future applications in plant protection and other fields. Here we report the production and recovery of a bioactive BP178 peptide using rice seeds as biofactories.ResultsA synthetic gene encoding the BP178 peptide was prepared and introduced in rice plants. The gene was efficiently expressed in transgenic rice under the control of an endosperm-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
25
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
2
1

Relationship

2
6

Authors

Journals

citations
Cited by 23 publications
(27 citation statements)
references
References 80 publications
(100 reference statements)
2
25
0
Order By: Relevance
“…Within our search for new AMPs to control plant diseases, we reported peptide conjugates incorporating units of the lead peptide BP100 and fragments of cecropin A, magainin II or melittin, which were specifically designed to be expressed in plants [17,18]. In fact, the peptide conjugate BP178 was successfully expressed in rice endosperm, showing resistance against some plant pathogens [19]. This demonstrates the availability of these peptides for being produced by the plant itself, which could overcome the difficulties in accessing the vascular location of Xf observed by other treatment strategies.…”
Section: Introductionmentioning
confidence: 99%
“…Within our search for new AMPs to control plant diseases, we reported peptide conjugates incorporating units of the lead peptide BP100 and fragments of cecropin A, magainin II or melittin, which were specifically designed to be expressed in plants [17,18]. In fact, the peptide conjugate BP178 was successfully expressed in rice endosperm, showing resistance against some plant pathogens [19]. This demonstrates the availability of these peptides for being produced by the plant itself, which could overcome the difficulties in accessing the vascular location of Xf observed by other treatment strategies.…”
Section: Introductionmentioning
confidence: 99%
“…However, the yields reported when using these systems were much lower than the AFP yield achieved in N. benthamiana using the TMV-derived system reported here. While our estimated yield of AfpB was approximately 250 lg per gram of fresh N. benthamiana leaf tissue, the reported yields for Retrocyclin-101 and Protegrin-1 were~5 and 8 lg/g of tobacco respectively (Lee et al, 2011), those for Cecropin A were~40 lg/ g of rice seeds (Montesinos et al, 2016), those for LL37 werẽ 0.55 lg/g of barley seeds (Hol askov a et al, 2018), and those for Lactoferrin chimera were~4.8 lg/g of tobacco hairy roots (Chahardoli et al, 2018). In addition, all of these plant-based production systems are based on stable transformation, which makes the process more complex and time consuming.…”
Section: Discussionmentioning
confidence: 53%
“…While challenging due to the physicochemical properties and toxicity of many of these peptides, some of these platforms successfully produce AMPs. These platforms include leaf chloroplasts (Lee et al ., ), rice seeds (Bundó et al ., ; Montesinos et al ., , ), barley seeds (Holásková et al ., ) and hairy roots (Chahardoli et al ., ). However, the yields reported when using these systems were much lower than the AFP yield achieved in N. benthamiana using the TMV‐derived system reported here.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite the physicochemical properties of some of these peptides, several plant-based platforms have been reported to be suitable for the large-scale production of AMPs. Among them, there are chloroplasts-based or rice seeds-based production systems (Lee et al, 2001;Montesinos et al, 2016;Montesinos et al, 2017). The success of these strategies is based on limiting the accumulation of AMPs to storage organs in order to avoid interference with plant vegetative growth; or to limit it to specialized subcellular organelles that would both protect AMPs from protease degradation and facilitate their purification (Montesinos et al, 2016;Montesinos et al, 2017).…”
Section: Biofactories For Amp Productionmentioning
confidence: 99%